![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 16/2818 | (2013.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/2803 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K2039/507 | (2013.01) | ||
A61P 43/00 | (2018.01) | ||
A61K2039/545 | (2013.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 15/00 | (2018.01) |
(11) | Patento numeris | 3263601 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17182243.0 |
Europos patento paraiškos padavimo data | 2013-10-02 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-01-03 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-24 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201261708784 P | 2012-10-02 | US |
(72) |
GRAZIANO, Robert F. , US
GUPTA, Ashok, K. , US
KIM, Su Young , US
WIGGINTON, Jon , US
|
(73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER |
COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER |